Survival of >20 years in a myeloma patient with an unusual combination of t(14;16) and hyperdiploidy: A case report

Oncol Lett. 2013 Dec;6(6):1663-1664. doi: 10.3892/ol.2013.1624. Epub 2013 Oct 11.

Abstract

The current case report presents the prolonged survival of >20 years in a myeloma patient with secondary plasma cell leukemia and myelomatous pleural effusion. FISH on marrow plasma cells showed hyperdiploidy and concomitant t(14;16) and karyotypes predicting superior and short survival. The possibility of primary hyperdiploidy with t(14;16) as a secondary event has been discussed.

Keywords: hyperdiploidy; myeloma; survival; t(14;16).